Could a special PET scan spot returning prostate cancer sooner?
NCT ID NCT07115914
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether adding a PSMA PET scan to the usual MRI can better detect prostate cancer that has come back after focal therapy. Focal therapy treats only the cancerous part of the prostate, but cancer can sometimes return. The PSMA PET scan uses a radioactive dye that sticks to prostate cancer cells, making them show up on images. Researchers will enroll 62 men who have had focal therapy to see if the PSMA PET scan finds more recurrences than MRI alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PSMA PET/CT scan (radioactive imaging dye)
- What this could lead to
- If successful, this could make it easier and more accurate to detect prostate cancer that comes back after focal therapy, potentially guiding earlier treatment.
- What could go wrong
- This is a small, early-stage study (62 participants) focused on imaging accuracy, not treatment. The PSMA PET scan may not prove better than standard MRI, and results may not apply to all prostate cancer patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
University of Chicago Medicine Comprehensive Cancer Center
RECRUITINGChicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sharper eye on prostate cancer return: PSMA PET vs. MRI
- AI may help spot dangerous prostate cancer and spare men from needless biopsies
- Blood test may spot prostate cancer without a needle
- A sharper eye on prostate cancer: could new imaging spare healthy tissue?
- Can a new drug combo tame resistant prostate cancer?
- Glow-in-the-dark dye may help surgeons spot hidden prostate cancer cells